Type 2 diabetes changes over time, and treatment regimens should adapt along the way. Adjusting A1c goals, shifting treatment priorities, and simplifying medication routines can all help optimize diabetes management.
[read_more text="read more" title="read more" url="https://tcoyd.org/2022/08/managing-type-2-diabetes-as-you-age/" align="left"]
Did you know there’s an injection-free way to treat high blood sugars? Inhaled insulin Afrezza is a fast-acting insulin that starts to work in minutes so you can have more freedom and spontaneity with your meal choices while still staying in control.
[read_more text="read more" title="read more" url="https://tcoyd.org/2022/08/inhaled-insulin-afrezza-an-under-utilized-treatment-in-the-type-2-toolbox/" align="left"]
What the heck is prediabetes? If you have it, does it mean type 2 is knocking at your door? Is there anything you can do to stop it from coming in? There’s a lot of fear and confusion surrounding prediabetes. Drs. E+P explain the risk factors, testing methods, and early treatment options that can help prevent or delay it from developing into type 2.
[read_more text="read more" title="read more" url="https://tcoyd.org/2022/07/prediabetes-its-not-too-late-for-an-about-face/" align="left"]
Drs. Edelman and Pettus discuss the novel type 2 medicine Mounjaro, a combination GLP-1/GIP that helps lower A1c and promote weight loss.
[read_more text="read more" title="read more" url="https://tcoyd.org/2022/06/say-buongiorno-to-mounjaro-a-new-blockbuster-diabetes-medication/" align="left"]
The FDA recently approved a novel medication called Mounjaro. See how this once-weekly therapy works to significantly lower A1c and promote weight loss in people with type 2 diabetes.
[read_more text="read more" title="read more" url="https://tcoyd.org/2022/05/mounjaro-reaching-a-new-peak-in-treating-type-2/" align="left"]
